The Covid-19 pandemic has been a boon to telemedicine as technology has matured and is readily available to all with low cost and the convenience of a mobile phone. At its height patients requiring assessment and follow-up, monitoring and therapeutic intervention as well as those in clinical trials had little choice but to risk face to face consultation with appropriate precautions and risk spreading infection, being infected or to embrace telemedicine.